These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5590216)

  • 1. [Complementary facts relative to the pharmacology of vasodilating substances and to hemodynamic consequences of their general administration in the treatment of obliterative arterial diseases of the lower limbs].
    Lambert J
    Rev Med Liege; 1967 Dec; 22(23):688-95. PubMed ID: 5590216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surhème and lower limb arteriopathies].
    Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):273-6. PubMed ID: 5164780
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
    Myers KA
    Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
    Caesar K
    Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of a new vascular drug, 4216 S, on circulatory flow in patients with chronic angiopathy of the lower extremities: determination of an index of vascularization of the lower extremities by serum albumin tagged with iodine 131].
    Dugois P; Bignicourt B
    Lyon Med; 1969 Jul; 222(27):43-7. PubMed ID: 5398723
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries.
    Schlüssel H
    Angiologica; 1966; 3(6):370-6. PubMed ID: 5958239
    [No Abstract]   [Full Text] [Related]  

  • 7. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
    Baitsch G; Schäfer M
    Med Welt; 1969 Aug; 35():1910-3. PubMed ID: 4897422
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

  • 9. The elimination of labelled antipyrine from muscle and skin of ischemic limbs during exercises before and after parenteral administration of vasodilating substances.
    Zetterquist S
    Scand J Clin Lab Invest Suppl; 1967; 99():225. PubMed ID: 6056926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of fenoxedil in peripheral artery diseases].
    Warembourg H; Thery C
    Lille Med; 1976 Jan; 21(1 suppl 1):4-7. PubMed ID: 1256230
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral vascular responses in the limbs. Is there a difference between the peripheral vascular responses of the upper and lower limbs?
    Walkey FA
    Angiology; 1978 Jan; 29(1):76-9. PubMed ID: 343653
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current problems in the pharmacotherapy of vascular diseases].
    Cahn J
    Minerva Med; 1976 May; 67(25):1621-7. PubMed ID: 934517
    [No Abstract]   [Full Text] [Related]  

  • 13. Paniverine of a new type for the management of obliterative arterial diseases.
    Bugár-Mészáros K; Fonó J
    Ther Hung; 1965; 13(4):151-5. PubMed ID: 5864163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pros and cons of vasodilator therapy in obliterative vascular diseases of the lower limbs].
    Thulesius O
    Lakartidningen; 1966 Oct; 63(43):4089-96. PubMed ID: 5977628
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic ischemia of the lower limbs by endoarterial administration of Mg and K aspartate].
    Gavrilescu S; Athanasesco I; Streiano C; Bartl F; Gabriel L
    Angeiologie; 1966; 18(4):15-22. PubMed ID: 5921115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases].
    Wenzel E; Nienhaus KH; Bahre G; Holzhüter H; Angelkort B; Meyer-Erkelenz
    Med Welt; 1976 Jun; 27(25):1242-7. PubMed ID: 933811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of an intra-arterially infused vasodilator (ATP) on the calf blood supply in dependence on dosage and severity of the blood circulation disorder].
    Grüntzig A; Bollinger A
    Dtsch Med Wochenschr; 1971 Aug; 96(35):1383-6. PubMed ID: 5565966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of obliterative arteritis of the lower limbs].
    Megret G
    Soins Cardiol; 1985; (30-31):28-31. PubMed ID: 3852455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arteriography of the lower limbs with papaverine vasodilators].
    Tamisier JN; Hoeffel JC; Royer JR
    J Belge Radiol; 1973; 56(2):121-8. PubMed ID: 4719264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Change of catecholamine level in the urine after the administration of vasodilating agents with chemical formulae related to adrenaline].
    Yamamoto T
    Nihon Geka Hokan; 1968 Jul; 37(4):567-70. PubMed ID: 5750048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.